← 產業報告目錄
Adrenocortical Hormones API Market Size, Share & Trends Analysis Report By Type (Dexamethasone Series, Betamethasone Series, Hydrocortisone Series & Others), By Application (Injectable Drugs, Oral Drugs, For External Use Drugs, Inhalation Drugs), By Region, And By Segment Forecasts, 2024-2031.
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-13頁數 180報告編號 INSIGHTACE-854acfaba0
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The Adrenocortical Hormones API Market on a global scale was estimated at USD 2.24 Bn in 2023 and is anticipated to attain USD 3.55 Bn by 2031, with a projected CAGR of 6.04% between 2024 and 2031.
At its core, Adrenocortical Hormones API pertains to steroid hormones synthesized by the adrenal cortex, which represents a component of the adrenal gland. Stakeholders across the healthcare landscape are expandingly turning to these solutions to meet contemporary demands.
The market's upward path is driven by expanding healthcare spending, technological evolution, and the expanding focus on personalized and precision-based approaches in healthcare.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region anticipated to deliver the strongest growth trajectory through the forecast period, driven by demographic shifts and policy support.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Adrenocortical Hormones API Market Snapshot
Chapter 4. Global Adrenocortical Hormones API Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type Estimates & Trend Analysis
5.1. by Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type:
5.2.1. Dexamethasone Series
5.2.2. Betamethasone Series
5.2.3. Hydrocortisone Series
5.2.4. Others
Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis
6.1. by Application & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
6.2.1. Injectable Drugs
6.2.2. Oral Drugs
6.2.3. For External Use Drugs
6.2.4. Inhalation Drugs
Chapter 7. Adrenocortical Hormones API Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Adrenocortical Hormones API Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
7.1.2. North America Adrenocortical Hormones API Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
7.1.3. North America Adrenocortical Hormones API Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
7.2. Europe
7.2.1. Europe Adrenocortical Hormones API Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
7.2.2. Europe Adrenocortical Hormones API Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
7.2.3. Europe Adrenocortical Hormones API Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
7.3. Asia Pacific
7.3.1. Asia Pacific Adrenocortical Hormones API Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
7.3.2. Asia-Pacific Adrenocortical Hormones API Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
7.3.3. Asia Pacific Adrenocortical Hormones API Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
7.4. Latin America
7.4.1. Latin America Adrenocortical Hormones API Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
7.4.2. Latin America Adrenocortical Hormones API Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
7.4.3. Latin America Adrenocortical Hormones API Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
7.5. Middle East & Africa
7.5.1. Middle East & Africa Adrenocortical Hormones API Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
7.5.2. Middle East & Africa Adrenocortical Hormones API Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
7.5.3. Middle East & Africa Adrenocortical Hormones API Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Sanofi (France)
8.2.2. GlaxoSmithKline (U.K.)
8.2.3. Xianju Pharma (China)
8.2.4. Teva (Israel)
8.2.5. Piramal Pharma Solutions
8.2.6. Guangzhou Tosun Pharmaceutical
8.2.7. BCN Peptides
8.2.8. Guangdong VTR Bio-Tech Co., Ltd,
8.2.9. Symbiotec Pharmalab,
8.2.10. Sun Pharmaceutical,
8.2.11. Cipla,
8.2.12. Hovione,
8.2.13. Shandong Xinhua Pharmaceutical Company Limited,
8.2.14. Steroid SpA,
8.2.15. Junye Pharmaceutical Co., Ltd.,
8.2.16. Avik Pharmaceutical,
8.2.17. Tianjin Pacific Pharmaceutical Co., Ltd (TJPP)
8.2.18. Shandong Sito Bio-technology CO., LTD.
8.2.19. Other Market Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們